CAS: 6283-25-6; 2-Chloro-5-Nitroaniline

上下游产品

CAS号10403-47-1 2-溴-5-硝基苯胺 | CAS号97-00-7 1-氯-2,4-二硝基苯 | CAS号95-51-2 2-氯苯胺 | CAS号136833-46-0 2-nitro-4-amino... | CAS号16588-15-1 2-氯-5-硝基苯甲酰胺 | CAS号22698-95-9 N-(2-氯苯基)邻苯二甲酰亚胺 | CAS号16588-02-6 2-氯-5-硝基苯甲腈 | CAS号533-17-5 N-(2-氯苯基)乙酰胺 | CAS号7697-37-2 硝酸 | CAS号7664-93-9 硫酸 | CAS号108086-37-9 2-氯-n-(2-氯-5-硝基... | CAS号108086-48-2 N-(2-chloro-5-n... | CAS号5381-78-2 1-甲基-5-硝基-1H -苯... | CAS号4533-95-3 2-氯-5-硝基苯磺酰氯 | CAS号41939-61-1 N1-甲基-4-硝基苯-1,2-二胺 | CAS号205827-96-9 N-(2-氯-5-硝基苯基)苯甲酰胺 | CAS号21762-74-3 6-硝基-2H-苯并[b][1... | CAS号100-00-5 对硝基氯苯 | CAS号96-72-0 2-氯-5-硝基苯磺酰胺 | CAS号30707-68-7 成色剂品-264硝基物

2-氯-5-硝基苯甲腈置于sodium Hydroxide,双氧水,溴体系中,化学反应生成 2-氯-5-硝基苯胺
参考文献:Blanksma,Recueil Des Travaux Chimiques Des Pays-Bas,1946,Vol. 65,P. 207,210
标题:Blanksma,Recueil Des Travaux Chimiques Des Pays-Bas,1946,Vol. 65,P. 207,210

专利信息

专利号:US-7658868-B2
优先权日:2002-03-20
标 题 :Molecular actuators, and methods of use thereof
发明人：ANQUETIL PATRICK A; HUNTER IAN W; MADDEN JOHN D; MADDEN PETER G; PULLEN ANTHONY E; SWAGER TIMOTHY M; XU BING; YU HSIAO-HUA
权利人:MASSACHUSETTS INST TECHNOLOGY; US NAVY
摘要:The synthesis of thiophene based conducting polymer molecular actuators, exhibiting electrically triggered molecular conformational transitions is reported. Actuation is believed to be the result of conformational rearrangement of the polymer backbone at the molecular level, not simply ion intercalation in the bulk polymer chain upon electrochemical activation. Molecular actuation results from Ï€-Ï€ stacking of thiophene oligomers upon oxidation, producing a reversible molecular displacement that leads to surprising material properties, such as electrically controllable porosity and large strains. The existence of active molecular conformational changes is supported by in situ electrochemical data. Single molecule techniques have been used to characterize the molecular actuators.

专利号:US-2016194279-A1
优先权日:2012-12-09
标 题 :One pot process for the conversion of aroyl chlorides to acyl thioureas
发明人：CHEPURI VENKATA RAMANA; BEERAN SENTHILKUMAR
权利人:COUNCIL SCIENT IND RES
摘要:The present invention disclose an improved one pot process for synthesis of acyl thioureas of formula (I), with yield greater than 80%, from aroyl chlorides of formula (I) wherein, R′ is an aryl or a heteroarylene group substituted with one or more groups selected from hydrogen, alkyl, alkylene, alkynyl, alkoxy, alkenyloxy, halo, hydroxyl, nitro, amino, carboxyl, ester, halogenated hydrocarbon or an aryl or heteroaryl; R″ and R′″ are selected independently from hydrogen, alkyl, alkylene, alkynyl, alkoxy, alkenyloxy, halo, hydroxyl, nitro, amino or halogenated hydrocarbon.

专利号:RU-2060994-C1
优先权日:1989-09-08
标 题 :Method of synthesis of aryltriazoline

专利号:RU-2070880-C1
优先权日:1994-04-08
标题 :Method of synthesis of 2-chloro-5-[$$$-(2',4'-di-tert-amylphenoxy)-butyroylamino]-anilide of pivaloylacetic acid

专利号:US-5105012-A
优先权日:1989-03-24
标题 :Catalytic reduction of dinitrobenzenes using a noble metal catalyst and iron or iron salts
发明人：THEODORIDIS GEORGE
权利人:FMC CORP
摘要:There is provided an improved process for the reduction of optionally substituted dinitrobenzenes to the corresponding nitroanilines with high yields which comprises contacting the dinitrobenzene with hydrogen in an acidic medium in the presence of a catalytic amount of a combination of a noble metal hydrogenation catalyst, and iron or an iron salt. Isomer specific reductions may be achieved with those compounds containing suitable directing substituents. The 2-halo-5-nitroanilines which may be produced in this process may be converted via a multi-step synthesis to useful 1-aryl-4-substituted 1,4-dihydro-5H-tetrazol-5-one herbicides.

专利号:US-11801242-B2
优先权日:2018-10-09
标 题:Compositions and methods for adjuvant cancer therapeutics
发明人：ZHOU PEI; HONG JIYONG
权利人:UNIV DUKE
摘要:This invention relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to translesion synthesis (TLS) pathway. More particularly, this disclosure relates to small molecule inhibitors of TLS, methods of inhibiting TLS pathway with these compounds, and methods of treating diseases related to the TLS pathway.